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Abstract
Background: Gender-based violence (GBV) undermines HIV prevention and treatment cascades, particularly among
women who report partner violence. Screening for violence during HIV testing, and prior to offering pre-exposure
prophylaxis (PrEP) to HIV uninfected women, provides an opportunity to identify those at heightened HIV risk and
greater potential for non-adherence or early discontinuation of PrEP. The paper describes our experience with
offering integrated GBV screening and referral as part of HIV counselling and testing. This component was
implemented within EMPOWER, a demonstration project offering combination HIV prevention, including daily oral
PrEP, to young women in South Africa and Tanzania.
Methods: Between February 2017 and March 2018, a process evaluation was conducted to explore views,
experiences and practices of stakeholders (study participants and study clinical staff) during implementation of the
GBV screening component. This article assesses the feasibility and acceptability of the approach from multiple
stakeholder perspectives, drawing on counselling session observations (n = 10), in-depth interviews with
participants aged 16–24 (n = 39) and clinical staff (n = 13), and notes from debriefings with counsellors. Study
process data were also collected (e.g. number of women screened and referred). Following a thematic inductive
approach, qualitative data were analysed using qualitative software (NVivo 11).
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Results: Findings show that 31% of young women screened positive for GBV and only 10% requested referrals.
Overall, study participants accessing PrEP were amenable to being asked about violence during HIV risk assessment,
as this offered the opportunity to find emotional relief and seek help, although a few found this traumatic. In both
sites, the sensitive and empathetic approach of the staff helped mitigate distress of GBV disclosure. In general, the
delivery of GBV screening in HCT proved to be feasible, provided that the basic principles of confidentiality, staff
empathy, and absence of judgment were observed. However, uptake of linkage to further care remained low in
both sites.
Conclusion: Most stakeholders found GBV screening acceptable and feasible. Key principles that should be in place
for young women to be asked safely about GBV during HIV counselling and testing included respect for
confidentiality, a youth-friendly and non-judgmental environment, and a functioning referral network.
Keywords: Gender-based violence, Screening, PrEP, HIV prevention, Adolescent girls and young women, Service
integration
Background
Gender-based violence (GBV) is a global public
health concern and a human rights violation [1, 2].
Overall, 30% of women worldwide have experienced
either physical or sexual intimate partner violence
(IPV) or non-partner sexual violence [1]. In Africa,
36.6% of women have experienced violence in their
lives, with adolescent girls and young women
(AGYW) being at high risk of IPV [1, 3]. Exposure
to GBV is associated with long-term health conse-
quences [2, 4], including HIV [5, 6]. Longitudinal
studies have shown that GBV increases HIV acquisi-
tion for women [5, 7–10], especially for adolescent
girls, who are at risk of transactional or forced sex
[11–13]. GBV also undermines HIV prevention and
treatment cascades [14–21]. Although findings are
mixed, studies indicate that women’s fear of IPV
prevents them from attending HIV counselling and
testing (HCT) services, and could affect uptake, ad-
herence or early discontinuation of PrEP [20], while
others have found that IPV is associated with poorer
ART adherence [14].
Despite the high prevalence and its adverse health ef-
fects, to date the health sector has had limited invest-
ments in addressing GBV [22]. GBV screening in health
care settings is not routinely recommended owing to in-
sufficient evidence on improved outcomes for women
[23] and to potential harm when no staff capacity or re-
ferral are available [24]. However, studies have shown
that it is acceptable to women [25], and can identify
those at risk of violence [26]. Most GBV screening inter-
ventions (primarily focusing on partner violence) have
been tested in antenatal care [27, 28] and primary health
care [29, 30], while only a few studies have integrated
GBV screening within HIV services [31–34]. While sug-
gesting that violence identification is feasible and accept-
able within HIV counselling services, research findings
from Southern Africa highlight barriers related to
individual providers (e.g. sporadic implementation due
to lack of time) and health facility conditions (e.g. lim-
ited referral services) that could affect its implementa-
tion by HIV providers [31, 34]. A recent systematic
review exploring the impact of IPV on women’s PrEP ac-
ceptability and use found scarce research on integration
of GBV issues and context within HIV prevention coun-
selling services [35]. Recent studies aiming to reduce
new HIV infections among AGYW shifted their focus
on minimising critical vulnerabilities such as GBV [36]
and reiterated the need for prevention strategies that ad-
dress violent behaviour or support young women in the
removal from their violent situation [37, 38]. However,
to our knowledge, only one pilot intervention study
(CHARISMA) – currently in its design phase and de-
signed to increase male partner support for female-
initiated HIV prevention intervention use - developed a
screening tool for partner violence and women’s safety
in the context of PreP delivery [39]. Though no accept-
ability and feasibility data are yet available for the CHAR
ISMA study. Research remains particularly scarce on
GBV response strategies that are acceptable for young
women and clinical staff in HIV prevention services.
Considering the limited evidence on the effects of GBV
on PrEP uptake and engagement, there is a need to
understand if and how GBV enquiry within PrEP ser-
vices could enable identification of those with a greater
potential for non-adherence or early discontinuation of
PrEP due to experiences or fear of GBV. Our paper at-
tempts to fill this evidence gap. This article aims to de-
scribe views and experiences with implementing GBV
screening and referrals within HCT in a larger PrEP
demonstration project (EMPOWER) that sought to as-
sess the acceptability and feasibility of a package of pre-
vention interventions, including oral PrEP, in South
Africa (hereafter SA) and Tanzania (hereafter Tz). EM-
POWER was implemented within the context of adoles-
cent and youth-friendly services (AYFS).
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Methods
Brief description of GBV screening and referral
component
Our definition of GBV encompassed any violence (phys-
ical, emotional, sexual and economic) perpetrated by
sexual partners, family members, peers or strangers. The
rationale for using a broad definition in developing the
GBV screening component is based on evidence showing
that AGYW experience both partner and non-partner
violence [11].
The GBV screening component included various activ-
ities (see Table 1 for more information). Before imple-
menting the screening, five study clinical staff (two HIV
counsellors in SA, and three clinical staff in Tz) were
trained on GBV identification by a GBV researcher.
Regular staff supervision was also provided to monitor
study fidelity.
Consenting EMPOWER participants were counselled
and tested for HIV at their first study visit, a prerequisite
for PrEP initiation and refills. As part of the HIV risk as-
sessment, participants were also screened for ever expe-
rienced (past and current) GBV by study clinical staff.
GBV screening was repeated at each clinic follow-up
visit (at 3 and 6months in both sites and at 9 months in
SA). The GBV screening and risk assessment questions
used for the study (see Fig. 1) were adapted from World
Health Organization (WHO) guidelines [28] and pre-
tested with young women outside the South Africa EM-
POWER cohort.
Participants found to be at immediate GBV risk of
harm (at risk of severe physical or sexual violence and/
or more severe mental health problems such as suicide)
were referred immediately to a place of safety for further
care, and counsellors discussed personalised safety plans
with them. With participants who disclosed abuse but
were not at immediate risk of harm, counsellors dis-
cussed referral options, organised referral if needed, and
offered opportunities for safety planning. Referral to
GBV support services was an integral part of the GBV
screening. Participants who disclosed GBV were also
followed up during adherence counselling visits within
the larger EMPOWER study to also ensure GBV did not
affect PrEP continuation.
Process evaluation: data collection and sampling of
participants
Between January 2017 and March 2018, we conducted a
process evaluation to explore the views, experiences and
practices of study participants and study clinical staff in
relation to the EMPOWER GBV screening component.
We used multiple data sources to assess the acceptability
and feasibility of integrating GBV screening into HCT
for AGYW.
We collected process data on the number of women
screened, screening outcomes, and the proportion re-
ferred to further services. Field notes from observations
of a random sample (n = 10) of integrated HCT/ GBV
screening sessions (conducted by MC between January
and February 2017) were included, as were notes from
regular debriefings with counsellors. Data were also col-
lected during in-depth interviews (IDIs) with 39 EM-
POWER participants (SA n = 25; Tz n = 14) aged 16–24,
3 months after enrolment in the larger study. Interview
participants were purposively sampled to capture a
broad spread of PrEP experiences and to match the
demographics of the larger study sample as far as pos-
sible, including women who became pregnant or sero-
converted during the study, and women who had
disclosed GBV. Semi-structured interviews were also
conducted with 13 study clinical staff (SA n = 10; Tz
n = 3). Table 2 describes the methods used, key ques-
tions explored and themes that guided our analysis.
Interviews were carried out by three trained re-
searchers in the language preferred by participants, in-
cluding English, isiZulu, and seSotho in SA, and Swahili
in Tz. Informed consent was sought for each interview,
Table 1 GBV screening and linkage to care component: activities/inputs
Description Implementation
Activities/inputs included:
- Training for study clinical staff
offering HCT
- GBV screening and risk
assessment job aid for study clinical
staff
- Safety planning job aid
- Material on GBV referral services
for staff and participants
- Staff supervision though
debriefing sessions
- Prior to study implementation, clinical staff offering GBV screening in HCT was trained on
GBV identification and risk assessment, first response (listening, validation, safety) and referral
procedures.
- An additional refresher training (on referral and communication skills) was also organised
after enrolment.
- GBV screening and risk assessment job aid was developed including 6 questions for identification
and 5 for risk assessment (asking about current safety and current risk of GBV).
- Prior to study implementation, EMPOWER team visited GBV referral services to select key services
for the study. A referral list for study staff was developed and subsequently revised every 3 months
to ensure accuracy of information. A pocket size card with referral services for GBV (e.g. shelters,
counselling, legal aid services) was also developed and offered to all participants during HCT
(irrespective of GBV positive disclosure).
- Warm referral (study staff directly contacting support services for appointment) was also offered by study staff.
- Regular debriefing sessions were given - by a GBV researcher - to study staff performing GBV screening to
discuss difficult cases and implementation challenges
- Staff counselling and support for vicarious trauma was organised for study staff (upon request).
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including for audio-recording it. Interviews took place at
the study clinics or a private place selected by partici-
pants. They were audio-recorded and subsequently tran-
scribed and translated into English, where necessary.
Data analysis
Following a thematic inductive approach [40], qualitative
data were analysed using qualitative software (NVivo
version 11; QSR International, Melbourne, Australia).
For interview data analysis, a qualitative team developed
a provisional codebook using a small selection of tran-
scripts. Once the codebook was finalised and inductive
coding of all transcripts was completed (by 2 coders),
reports were then generated for specific nodes (e.g. ex-
periences of GBV screening, views on GBV screening
questions; views on integration of GBV into HCT) and
summary matrices were developed to examine intersect-
ing themes (including feasibility, acceptability and pa-
tients’ response). Two coding and analysis workshops
were held to discuss interpretation of the data. Key
themes from observational data (e.g. fidelity) and meet-
ing notes were integrated with interview data as needed.
Themes explored included: acceptability of and experi-
ences with GBV screening process, feasibility of and
challenges with GBV screening. Representative quotes
were selected to illustrate key themes.
Fig. 1 GBV screening algorithm
Table 2 Data collection methods, key questions and themes that guided the analysis
Themes guiding the
analysis
Key questions Data collection methods
Process data on GBV
screening
How many women were screened for GBV?
How many experienced GBV?
How many women were referred?
▪GBV screening outcome forms
Fidelity How has GBV screening been delivered?
How much of the GBV screening was delivered as intended?
• What parts were not delivered?
• Challenges to delivery?
▪In-depth interviews with study
clinical staff
▪Observations of GBV screening
sessions
▪Notes from debriefing meetings
with counsellors
Feasibility What were barriers and facilitators to GBV screening? ▪In-depth interviews with study
participants and study clinical staff




What are young women’s views and perceptions of the GBV screening?
How did young women respond to GBV screening?
What are study clinical staff’s perceptions of GBV screening?
▪In-depth interviews with study




Were there any side-effects/unintended consequences when delivering GBV
screening? (i.e. on the study participants or study clinical staff)
▪In-depth interviews with study
clinical staff and with study participants
▪Notes from debriefing meetings with
counsellors
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Ethical approval
The study was approved by the Human Research Ethics
Committee of the University of the Witwatersrand (SA),
the London School of Hygiene and Tropical Medicine
Ethics Committee, and the Tanzanian National Health
Research Ethics Committee of the National Institute for
Medical Research (Tz).
Results
GBV screening outcome: GBV prevalence and referrals
A total of 563 participants were screened for GBV
during HCT, of which 175 (31%) reported ever having
experienced GBV. Only 2 cases (in SA) were at im-
mediate risk of harm and needed an immediate re-
sponse. The remainder (n = 173) had experienced
mostly physical and psychological violence, but were
not at immediate risk for further harm. It is worth
noting that sexual violence was significantly higher in
Tz (62%) than in SA (28%). Only a few (SA n = 10;
Tz n = 2) requested referrals to support services.
Table 3 offers detailed information.
Socio-demographic characteristics of study participants
interviewed
In SA, most study participants interviewed qualitatively
were tertiary-level students living with family or in stu-
dent residences. Most Tz participants had only com-
pleted primary school, were living alone or with family
members, and worked full time in food and alcohol out-
lets. In both sites, there was a high prevalence of GBV,
with roughly half of the participants in the qualitative
sub-sample reporting ever experienced any violence
(Table 4).
Experiences with GBV screening implementation
Fidelity
GBV screening was largely delivered as intended.
Findings from observations of HCT sessions show
that counsellors followed the GBV screening script,
took time to explain confidentiality of GBV discus-
sions, conducted risk assessments and offered infor-
mation on GBV referral options - and safety tips
when needed - to all study participants. However,
debriefing discussions (in SA) highlighted some initial
challenges. Firstly, traditional safety planning could
not always be implemented, as most study
Table 3 GBV prevalence, types and referrals among participants screened for GBV at enrolment in the EMPOWER study
SA n = 482 Tz n = 81 Total n = 563
GBV reported at screeninga 146 (30%) 29 (36%) 175 (31%)
Type of violence reported
Sexual 41 (28%) 18 (62%) 59 (34%)
Psychological 62 (42%) 17 (59%) 79 (45%)
Physical 72 (49%) 9 (31%) 81 (46%)
Economic 6 (4%) 1 (3%) 7 (4%)
More than 1 type 29 (20%) 12 (43%) 41 (23%)
At risk of immediate harm 2 (1%) 0 2 (1%)
Referral requested and organiseda 10 (7%) 2 (7%) 10 (6%)
(areported by women and recorded in GBV Screening Outcome Forms by study counsellors)
Table 4 Socio-demographic characteristics of EMPOWER study
participants interviewed (including GBV cases)
South Africa Tanzania





Primary school or less 0 6
Some Secondary School 3 3
All Secondary School 8 5
Some Tertiary education 14 0
Residence
Alone (or in student residence) 6 5
Parents 12 3
Partner 0 1
Other relatives 7 5
Relationship status
Single (not married) 25 12
Living with partner 0 1
Married 0 0
Separated or divorced 0 1
Occupation
None 22 1
Full time 0 12
Part-time 3 1
Screened positive for GBV 13 7
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participants were not living with their partners. In-
stead, counsellors developed additional safety tips tai-
lored to participants’ individual situations. Secondly,
immediate risk of harm was often partially assessed.
However, early debriefings with the counsellors
helped clarify the intended procedure for risk assess-
ment. Both sites activated linkage to mental health
services following screening, by referring cases to a
social worker in an adjacent clinic for counselling
(SA) or to a trained counsellor (Tz).
Clinical staff views on feasibility of integrating GBV
screening into HCT
In SA, study counsellors found integration of GBV
screening into HCT feasible, provided training and
staff support was available. Many appreciated the
regular GBV debriefings, which helped ‘unbottle’ their
initial discomfort and emotional toll when asking
about GBV, and release stress so that they did not
need to ‘take it home’.
‘[ … ] So if I come across that [GBV case] I do get
support because I get debriefing [ … ] It helps a lot
because what I’ve learned is, through all the experi-
ences that I have gone through, that when you bottle
up things it doesn’t help, you see, but talking about
them helps a lot because like you don’t sort of like
carry anything in you’. [clinical staff, SA]
Study staff in both countries reported challenges with
referral uptake with only a few participants (SA = 10;
Tz = 2) accepting referral to support services, mainly for
counselling and mental health services. In SA, having
direct access to a social worker facilitated warm referral
and follow up of referred GBV cases.
‘Like here [at study clinic] we are lucky in that we
got a social worker downstairs [...] you can pick up a
phone and speak to someone directly [social worker]
and say “listen, I need you to get this person”’. [clin-
ical staff, SA]
When referral to counselling was organised externally,
some reported not attending. In Tz, traditional norms
on intimate relationships and GBV (e.g. seen as a private
family issue) deepened participants’ reluctance to seek
help.
‘[ … ] she does tell you [about GBV], but she says it’s
just a story and you shouldn’t take it anywhere [ … ]
Yes, it has happened to her. Ehee but she doesn ’t
prefer the support because ‘it ’s not in our
customs to report your husband’. [clinical staff,
Tz].
Because of the shyness that characterises some
AGYW and pervasive cultural norms that discour-
age them from being sexually active, staff men-
tioned the added value of delivering GBV screening
within the context of an adolescent and youth-
friendly service.
“[ … ] our approach like I said, the youth-friendliness,
also makes it easier for them [AGYW] to be able to
open up and talk [about GBV]'. [clinical staff, SA]
Debriefings with counsellors (in SA) also revealed
their uneasiness when some participants asked for ad-
vice on how to disclose PrEP use to their partners as
they feared violence and rejection from their partners.
Counsellors felt they lacked the necessary training or
knowledge required to counsel young people on sex-
ual relationships.
AGYW’s perspectives on acceptability of the GBV
screening and participants’ response Nearly all
AGYW interviewed reported that they had never been
asked about GBV experiences by a health provider.
Almost all AGYW found GBV screening acceptable –
even women who did not disclose any GBV – and re-
ported this as a positive experience. Participants saw
the GBV screening as helping them reflect on their
relationships and challenging their traditional views
on GBV. For some, screening offered an opportunity
to discuss their GBV experience, which led to some
relief.
“Eish those questions were provoking my thoughts... [
… ], they provoke you to talk and participate, tell
her [counsellor] and interact with her". [GBV ex-
perience, 21 years, SA]
Many reported that discussing GBV was reassuring, as
they felt that someone was willing to offer help.
‘I felt good. [ … ] Sometimes when you tell them that
I have been violated with certain kind of violence
they could help you to find lawyers.’ [GBV experi-
ence, 24 years, Tz]
Irrespective of their past GBV experience, several par-
ticipants reported becoming more aware and
knowledgeable about GBV and gender norms through
their counselling sessions.
‘In truth I felt good because they explained to me
matters that I didn’t even know and I understood. [
… ] That day I learned about gender violence’. [no
GBV experience, 21 years, Tz]
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Even participants who reported no abuse said that the
counselling provided useful information about GBV
referrals.
‘[Screening was] unexpected but it was exciting ‘cos I
got to explain how it made me feel and how I saw it
in my eyes, so it gives me an opportunity to express
myself”. [GBV experience, 18 years, SA]
Only one participant acknowledged the importance of
GBV screening to help prevent HIV acquisition.
‘You are asked on your relationship issues, gender
violence... Yes, it is appropriate [to be asked about
GBV during HCT] because others get infected, they
are violated, raped.’ [GBV experience, Tz]
However, a handful of participants who had experi-
enced past violence said that being asked about abuse
had been traumatic and uncomfortable, as they had
never disclosed the violence before. For some, the ques-
tions felt “too personal” or they found it difficult to share
their experiences, especially in relation to sexual vio-
lence. One participant found GBV screening hard at
first, as it brought back memories of her rape experience
that she wanted to forget.
‘For me, it was just traumatising because she took
me back to... you know... the past, ja, I have experi-
enced some violence myself. So, we had to talk about
that, and it was quite sad because it was something
I wanted to forget, but ja". [GBV experience, 19
years, SA]
However, she later reflected that discussing the vio-
lence had been helpful to move on. One woman shared
that with time, familiarity with the counsellors made dis-
cussing GBV easier during follow-up visits.
‘[ … ] At first, it was like for the first time and some
things were personal. I … It was not easy at first but
now it is easy ‘cos every time when I come, I always
see them [the counsellors] and talk to them, ja."
[GBV experience, 21 years, SA]
Disclosing GBV to the counsellor was reported to be
emotionally easier for AGYW who had already left the
abusive relationship or had received previous counsel-
ling, as this meant that they had already begun to ad-
dress their emotional distress.
‘ … it was not that hard for me because I had left
the guy and I have forgiven myself and him … so it
was not like... the lady brought up something, no, I
didn’t have the anger and stuff." [ GBV experience,
22 years, SA]
In the interviews, AGYW spoke about their appreci-
ation of the study staff, depicting them as kind, friendly
and caring. They found a number of qualities valuable in
the staff, including the fact that they were non-
judgmental and understanding, reacted positively to
GBV disclosure, and did not force disclosure but ac-
cepted women’s decision not to share any painful
experience.
‘She [counsellor] understands, she talks to you
kindly, she doesn’t even push you to say things you
don’t want to say, she just goes with the flow". [GBV
experience, 22 years, SA]
‘They do their work whole heartedly; they aren’t dis-
criminative in any way … I felt free’. [no GBV ex-
perience, 19 years, Tz]
Confidentiality of GBV screening was also critical for
the AGYW. They trusted the counsellors for respecting
their privacy and did not fear that any disclosed infor-
mation would be divulged.
‘Because it’s private here [at study clinic] and I am
assured that my personal answers will not go around
everywhere.’ [no GBV experience, 19 years, SA]
When asked about barriers to integrating screening
into routine HCT, some AGYW described the potential
for women to conceal abuse out of fear of partner retali-
ation. Some worried that GBV screening could lead to
increased risk of violence among women who were cur-
rently in abusive relationships. However, no study partic-
ipants reported experiencing such unintended negative
consequences.
‘With people that are in violent situations, I don’t
think … they would be comfortable with that [GBV
screening]. [ … ] they even hide that I am in a vio-
lent relationship Because they know why “he is
gonna come back for me. So let me just not touch it,
you see. They won’t [disclose].’ [no GBV experience,
18 years, SA]
Discussion
To our knowledge, this was one of the first published
studies to assess the feasibility and acceptability of inte-
grating GBV screening into HCT services for AGYW
taking PrEP. Our findings show that a third of AGYW
screened for GBV prior to enrolment in the
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demonstration project disclosed violence, though only
10% accepted support referral. Overall, participants were
amenable to being asked GBV questions, as this offered
the opportunity to find emotional relief and seek help.
Although the majority reported having a positive experi-
ence, for a few who reported past sexual violence screen-
ing was traumatic as it caused them to revisit past
trauma. In both sites, the sensitive and empathetic ap-
proach of the staff helped mitigate such distress. In gen-
eral, the delivery of GBV screening in HCT in a PrEP
study proved to be acceptable, provided that the basic
principles of confidentiality, staff empathy, and absence
of judgment were observed. However, uptake of linkage
to further care remained low in both sites.
Crucial requirements for delivering GBV screening in-
cluded continuous training on basic response and sup-
port of staff. The study reaffirms the evidence that
experiential learning – through regular debriefings – is
crucial for maintaining staff knowledge, increasing self-
efficacy and shaping providers’ practices [41, 42]. Men-
toring programmes and group discussions of difficult
GBV cases with more senior clinical staff could help
mitigate challenges. However, integrating such practice
into busy and overstretched HIV clinics may be difficult
[23, 43]. Health managers should ensure clear protocols
and care pathways for discussing GBV are in place, and
a supportive environment for clinical staff to overcome
such barriers.
Although having a referral system is critical when
screening for GBV in health services [26], it is worth ac-
knowledging the limited uptake of referral services by
participants in this study. This is in line with current evi-
dence showing complex reasons for such disparities (be-
tween formal referral and uptake), including low trust in
the quality of formal services, cultural norms (e.G.
stigma, fear of family repercussions), time and financial
constraints [44–46]. More research is clearly warranted
on referral preferences among AGYW, however. In both
sites, having direct access to a social worker or trained
counsellor facilitated GBV referrals uptake, as also evi-
denced elsewhere [41, 47, 48]. Some women still pre-
ferred to talk only to the study staff and were wary and
distrustful of external services. Though in practice, hav-
ing on-site support may not be a viable option in all
public clinics, alternative linkages to quality support ser-
vices should be put in place before integrating GBV
screening into HCT, particularly for psychological care.
However, such services are often unavailable, under-
developed, and stigmatized, although they are urgently
needed for this age group [49].
Low relationship power in itself is an important pre-
dictor of HIV risk and IPV among AGYW [50], and
AGYW may have little power in their intimate relation-
ships to elicit support for PrEP use from partners. Our
study has shown the need for training PrEP counsellors
to also discuss power relations within sexual partner-
ships and gender inequality more broadly with AGYW.
Additional investigation into how training could also ad-
dress communication skills when discussing PrEP adher-
ence with this group is critical. Ideally, PrEP counselling
should offer a safe space for AGYW to discuss relation-
ship concerns and GBV experiences that could affect
PrEP engagement.
Our findings also suggest the importance of having
a youth-friendly approach. Kindness, privacy, time,
empathy and lack of judgement were all reported as
factors facilitating GBV disclosure. Evidence from
sub-Saharan Africa shows that some of these elements
are poorly implemented in public clinics due to lack
of youth-friendly training among staff, no dedicated
space for young people, and low respect for confiden-
tiality – all of which hinder the potential integration
of violence identification for adolescents [51–53].
While the GBV screening component in EMPOWER
was relatively simple to implement, the importance of
training staff to be sensitive, non-judgemental, and to
provide confidential services should not be underesti-
mated [34, 54].
Lastly, when conducting GBV screening for AGYW,
we have learned the importance of going beyond IPV
and dating violence to also focus on non-partner sexual
violence, as recommended by regional studies [11]. In
our study, many participants (in both sites) were unmar-
ried and not living with partners, which affected how
safety could be practically secured for this group. Fur-
ther research is critical to explore preferences and adapt
safety plans and tips, and tailor them to the specific so-
cial circumstances of the target group.
Limitations
The GBV screening evaluation was conducted in the
context of a demonstration study rather than in rou-
tine HIV services, at a time when PrEP was not yet
standard of care. However, the information in this
article offers useful insights into factors affecting ac-
ceptability and feasibility for programme designers
seeking to integrate GBV screening into HIV preven-
tion and care settings for AGYW. Although most in-
terviews were conducted by researchers not involved
in the study, it is possible that participants viewed
them as study implementers and gave socially desir-
able responses that showed the screening in a positive
light. Furthermore, observing counselling sessions may
have made counsellors behave differently because they
knew they were being observed. Lastly, differences in
samples from the two countries (particularly as it re-
lates to their household configurations) might have
affected some of the conclusions drawn around safety.
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Conclusion
Most stakeholders found integrated GBV screening in
an HCT and PrEP context acceptable and feasible. Fu-
ture GBV screening interventions for AGYW within
HCT should consider key principles such as respect for
confidentiality, a youth-friendly and non-judgmental en-
vironment, and ensuring safety. A functioning referral
network, experiential learning and mentoring were crit-
ical for sustaining GBV screening and should not be
underestimated in future similar interventions.
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